- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03127371
Adjunctive Nitrous Oxide During ED Incision and Drainage of Abscess
Adjunctive Nitrous Oxide to Lidocaine Anesthesia During ED Incision and Drainage of Abscess in Adults: A Randomized Controlled Trial
Study Overview
Detailed Description
This study will be a prospective, randomized, double-blinded clinical trial of patients undergoing incision and drainage of abscesses in the ED of an urban, tertiary, academic medical center. Subjects will be randomized to one of two groups: 100% oxygen or 50/50 O2/Nitrous oxide while undergoing standard incision and drainage of cutaneous abscess.
Recruitment Methods
The research associates as well as the heath care team (both residents and attending physicians) will screen patients who may need incision and drainage of abscesses in the ED and may qualify for the study. Research associates will use the Cerner/AeCIS System for screening, and they will be in charge of informed consent, enrollment, placement of the capnography monitor, as well as data collection. The health care team will be in charge of the local anesthesia and incision and drainage of abscess and all other management.
Procedures Involved in the Research
Initial medical assessment will be made in accordance with established clinical procedures, including the history, physical examination, and vital signs. If by clinical assessment the patient meets eligibility criteria, then they will be approached by a research associate for enrollment in the study. After informed consent is obtained and prior to starting the procedure, standard vital sign monitoring will be placed on the patient (electrocardiogram, non-invasive blood pressure monitoring, pulse oximetry, and capnography). The Capnostream 20 ETCO2 monitor will be used as the primary device to measure ETCO2, with a nasal cannula capable of delivering supplemental oxygen and measuring ETCO2 (Oridion Medical, Needham, MA).
The SEDARA gas mixer system [Linde Gas North America LLC] will be used as our primary nitrous oxide delivery device. It will mix and deliver nitrous oxide and oxygen in a 1:1 ratio, at a fixed concentration of 50%/50%. It uses a patient driven demand valve system that is hand held. This device provides a consistent, fixed 50%/50% blend of nitrous oxide (N2O) and oxygen (O2), eliminates the need to titrate, and provides fixed concentrations for controlled and consistent dosing. The device comparator detects dosing imbalance to protect against hypoxic mixtures, it cannot deliver nitrous gas without concurrent oxygen, and the device has an anti-asphyxia valve override. The on demand valve requires patient inspiration to trigger dosing and also allows option for 100% oxygen delivery through same delivery mask. This portable device scavenges exhaled waste gases for environmental safety, as well as a key mechanism that renders the system inoperable without it for security.
After informed consent, the patient will fill out a pre procedure questionnaire and a 100 mm VAS baseline pain scale. The patient will be randomized to either the control group (100% oxygen) or treatment group (50/50) by using a randomization scheme generated using the web site Randomization.com (http://www.randomization.com). The treating physician will measure erythema and induration using a measuring tape, estimate the amount of fluctuance as small, moderate, or large, and note the location of the abscess. Once randomized, subjects will be given the mask for delivery of inhaled gas and instructed on its use, and the research associate will mark the time the patient began using the device. The SEDARA Gas Mixer will be only facing the research associate as to ensure blinding of study arm by provider and subject. The subject will be given nitrous oxide or oxygen for a minimum of 10 minutes prior to incision and drainage. The treating physician will then clean the abscess with chlorhexidine solution. The abscess will be incised with a single linear incision using a No. 11 surgical scalpel, and a cotton tipped applicator will be used to break up loculations within the abscess cavity. The method of I&D, and decision to probe to break-up loculations will be standardized, but the degree of probing, depth, and decision to pack will be left to the discretion of the treating physician. Subjects pain will be assessed using the VAS at ten minutes after NO administration but before beginning I&D, immediately post I&D procedure, and ten minutes after procedure completion.
The subject's clinical data (refer to data management) will be entered into a standardized data collection form. Study will end when the subjects recovers back to baseline. Vital signs will be flagged electronically when a physician intervenes for clinical respiratory depression. Respiratory depression will be defined as peripheral SaO2 below 92%, ETCO2 level above 50, a rise or decrease of 10% above or below baseline, the loss of the ETCO2 waveform for more than 15 seconds. Once the procedure is complete, and the patient is deemed back to their mental status baseline, they will fill out a post procedure satisfaction questionnaire. The physician will also fill out a post procedure questionnaire.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19141
- Einstein Medical Center Philadelphia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients 18 years of age or older with cutaneous abscesses located on the trunk or extremities that required I&D were approached and offered participation in the study. Need for I&D was left to discretion of treating physician.
Exclusion Criteria:
- Abscesses larger than 5 cm in any dimension
- Abscesses located on the face, neck, scalp, hands, feet, perianal, rectal, or genital areas.
- Subjects with underlying conditions that could affect ventilation, perfusion, or metabolism including intubated subjects, history of COPD, subjects with clinical signs of cardiopulmonary instability, major trauma, shock, sepsis, ASA class 3, 4, and 5.
- Those unable to provide informed consent, nursing home residents, age less than 18 years, non-English speaking, pregnant women, subjects under police custody, or physician discretion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nitrous Oxide
Patients undergoing incision and drainage of abscess will undergo an initial medical assessment including the history, physical examination, and vital signs.
The patients will then receive Nitrous Oxide gas via a gas mixer device while undergoing standard incision and drainage of cutaneous abscess using lidocaine local anesthesia administered subcutaneously.
The device will mix and deliver nitrous oxide and oxygen in a 1:1 ratio, at a fixed concentration of 50%/50%.
The on demand valve requires patient inspiration to trigger dosing.
|
Patients undergoing incision and drainage of abscess will undergo an initial medical assessment including the history, physical examination, and vital signs.
The patients will then receive Nitrous Oxide gas via a gas mixer device while undergoing standard incision and drainage of cutaneous abscess .
The device will mix and deliver nitrous oxide and oxygen in a 1:1 ratio, at a fixed concentration of 50%/50%.
The on demand valve requires patient inspiration to trigger dosing.
Other Names:
|
Experimental: Oxygen
Patients undergoing incision and drainage of abscess will undergo an initial medical assessment including the history, physical examination, and vital signs.
The patients will then receive 100% oxygen gas via the Nitrous Oxide gas mixer device while undergoing standard incision and drainage of cutaneous abscess using lidocaine local anesthesia administered subcutaneously.
The device will deliver only oxygen at a fixed concentration of 100%.
The on demand valve requires patient inspiration to trigger dosing.
|
Patients undergoing incision and drainage of abscess will undergo an initial medical assessment including the history, physical examination, and vital signs.
The patients will then receive 100% oxygen gas via the Nitrous Oxide gas mixer device while undergoing standard incision and drainage of cutaneous abscess .
The device will deliver only oxygen at a fixed concentration of 100%.
The on demand valve requires patient inspiration to trigger dosing.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in VAS pain score from baseline
Time Frame: Through study completion, an average of 45 minutes
|
VAS measured pre-anesthesia, pre-procedure, immediately post procedure, and 10 minutes following procedure.
|
Through study completion, an average of 45 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nitrous oxide duration
Time Frame: day 1
|
Total number of minutes Nitrous oxide was inhaled by patients
|
day 1
|
Physician Satisfaction Survey
Time Frame: day 1
|
Physician satisfaction with use of Nitrous oxide/Oxygen in pain control
|
day 1
|
Patient Satisfaction Survey
Time Frame: day 1
|
Patient satisfaction with use of Nitrous oxide/Oxygen in pain control
|
day 1
|
Pulse Rate
Time Frame: day 1
|
beats per minute
|
day 1
|
Respiratory Rate
Time Frame: day 1
|
breaths per minute
|
day 1
|
Blood Pressure
Time Frame: day 1
|
mmHg
|
day 1
|
Continuous Oxygen Saturation
Time Frame: Baseline until 10 minutes following procedure
|
Oxygen saturation measured every 20 milliseconds captured by a monitoring device during study period
|
Baseline until 10 minutes following procedure
|
Continuous End tidal CO2
Time Frame: Baseline until 10 minutes following procedure
|
End tidal Co2 measured every 20 milliseconds captured by a monitoring device during study period
|
Baseline until 10 minutes following procedure
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joseph P Herres, DO, Albert Eisntein Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HN4861
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abscess
-
Hospital Italiano de Buenos AiresUnknownLiver Transplant AbscessArgentina
-
Inje UniversityPusan National University Yangsan HospitalCompletedCryptogenic Pyogenic Liver AbscessKorea, Republic of
-
Manchester University NHS Foundation TrustUniversity of Liverpool; University of Birmingham; National Institute for Health... and other collaboratorsCompletedPerianal Abscess | Perianal Infections | Peri Rectal Abscess | Abscess; Anus | Abscess AnorectalUnited Kingdom
-
Kaohsiung Veterans General Hospital.BayerCompletedLiver AbscessTaiwan
-
Northwell HealthPediatric Surgical Research CollaborativeActive, not recruitingPilonidal Disease | Pilonidal Sinus Without Abscess | Pilonidal Cyst/Fistula | Pilonidal Cyst Without Abscess | Pilonidal Cyst and Sinus Without Abscess | Pilonidal Abscess | Pilonidal Sinus With Abscess | Pilonidal Dimple With Abscess | Pilonidal Fistula With Abscess | Pilonidal Sinus Infected | Pilonidal... and other conditionsUnited States
-
Kaiser PermanenteGenentech, Inc.CompletedAbdominal Abscess | Pelvic AbscessUnited States
-
Dow University of Health SciencesCompleted
-
The Hospital for Sick ChildrenTerminated
-
Hannover Medical SchoolBayerCompletedAbscess, Intra-AbdominalGermany
-
Nanfang Hospital of Southern Medical UniversityRecruitingInfections | Abscess | Liver Abscess | Liver Abscess, PyogenicChina
Clinical Trials on Nitrous Oxide
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
State University of New York at BuffaloCompleted
-
Washington University School of MedicineBrain & Behavior Research FoundationCompletedDepressive Disorder, Major | Depressive Disorder, Treatment-ResistantUnited States
-
Beth Israel Deaconess Medical CenterRecruitingProcedural Pain | Pain Catastrophizing | Procedural AnxietyUnited States
-
Beth Israel Deaconess Medical CenterBoston Children's HospitalCompletedLower Urinary Tract SymptomsUnited States
-
Beth Israel Deaconess Medical CenterBrigham and Women's HospitalCompletedPain | Benign Prostatic Hyperplasia | Prostate Cancer | Prostate Adenocarcinoma | Anxiety and Fear | Malignancy | Prostate DiseaseUnited States
-
Washington University School of MedicineFoundation for Anesthesia Education and ResearchCompletedCardiovascular AbnormalitiesUnited States
-
National Institute of Diabetes and Digestive and...CompletedAvitaminosis | Delirium, Dementia, Amnestic, Cognitive DisordersUnited States
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Baxter Healthcare CorporationCompleted